Millennium Management’s Skye Bioscience SKYE Stock Holding History
Bought
Maintained
Sold
Other funds holding SKYE
BBA
Millennium Management's SKYE Position: Q3 2026 in Review
Millennium Management reduced its Skye Bioscience (SKYE) stake by 41% in Q3 2026, selling an estimated $35.1K and leaving 14,611 shares worth $23.5K. The position accounts for ﹤0.01% of the portfolio, ranked #5980.
Millennium Management first reported a position in SKYE in Q3 2024 and has held it in 7 quarters since. The position peaked at $1.97M in Q2 2025. 31 funds tracked by Wall St. Rank hold SKYE as of Q3 2026.
- Millennium Management held 14,611 shares of Skye Bioscience worth $23.5K as of Q3 2026.
- Millennium Management sold 10,205 Skye Bioscience shares in Q3 2026, an estimated $35.1K.
- Skye Bioscience made up ﹤0.01% of Millennium Management's portfolio in Q3 2026, its #5980 holding.
- Millennium Management first reported a position in Skye Bioscience in Q3 2024 and has held it in 7 quarters since.
- Millennium Management's Skye Bioscience position peaked at $1.97M in Q2 2025.
- 31 funds tracked by Wall St. Rank held Skye Bioscience as of Q3 2026.
Based on Millennium Management's 13F filing for Q3 2026, filed 16 Nov 2026.